Brief: Shilpa Medicare Says US Approval For Varenicline Tablets
09/04/2025 12:38
April 9 (Reuters) - Shilpa Medicare Ltd SHME.NS: US APPROVAL FOR VARENICLINE TABLETS RECEIVED APPROVAL FROM USFDA FOR VARENICLINE TABLETS, 0.5 AND 1 MG Source text: ID:nBSE1NbXmT Further company coverage: SHME.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026